BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1997737)

  • 1. Morphology of menstrual hemostasis in essential menorrhagia.
    van Eijkeren MA; Christiaens GC; Geuze JJ; Haspels AA; Sixma JJ
    Lab Invest; 1991 Feb; 64(2):284-94. PubMed ID: 1997737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia.
    van Eijkeren MA; Christiaens GC; Geuze HJ; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1992 May; 166(5):1419-28. PubMed ID: 1595797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology of the hemostatic plug in human skin wounds: transformation of the plug.
    Wester J; Sixma JJ; Geuze JJ; Heijnen HF
    Lab Invest; 1979 Aug; 41(2):182-92. PubMed ID: 459434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphologic characteristics of menstrual hemostasis in patients with unexplained menorrhagia.
    Hourihan HM; Sheppard BL; Bonnar J
    Int J Gynecol Pathol; 1989; 8(3):221-9. PubMed ID: 2767871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology of the early hemostasis in human skin wounds: influence of acetylsalicylic acid.
    Wester J; Sixma JJ; Geuze JJ; van der Veen J
    Lab Invest; 1978 Sep; 39(3):298-311. PubMed ID: 362066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemostatic mechanism and menstruation: the role of intra-uterine contraceptive devices.
    Rajah SM; Foley ME; Clayton JK; Aparicio SR; Bird CC; McNicol GP
    Thromb Haemost; 1980 Feb; 42(5):1548-56. PubMed ID: 7368156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Fraser IS; McCarron G; Markham R; Resta T; Watts A
    Obstet Gynecol; 1986 Nov; 68(5):630-3. PubMed ID: 3763074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
    Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
    Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
    Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
    Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
    Janssen CA; Scholten PC; Heintz AP
    Obstet Gynecol; 1995 Jun; 85(6):977-82. PubMed ID: 7770270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.
    Kouides PA; Conard J; Peyvandi F; Lukes A; Kadir R
    Fertil Steril; 2005 Nov; 84(5):1345-51. PubMed ID: 16275228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of menstrual flow by weighing protective pads in women with normal, decreased or increased menstruation.
    Gudmundsdottir BR; Hjaltalin EF; Bragadottir G; Hauksson A; Geirsson RT; Onundarson PT
    Acta Obstet Gynecol Scand; 2009; 88(3):275-9. PubMed ID: 19137461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of dysfunctional uterine bleeding.
    Sheppard BL
    Clin Obstet Gynaecol; 1984 Apr; 11(1):227-36. PubMed ID: 6370534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.
    Chimbira TH; Anderson AB; Turnbull Ac
    Br J Obstet Gynaecol; 1980 Jul; 87(7):603-9. PubMed ID: 7426516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology of haemostasis in menstrual endometrium.
    Christiaens GC; Sixma JJ; Haspels AA
    Br J Obstet Gynaecol; 1980 May; 87(5):425-39. PubMed ID: 6992851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Menorrhagia and hemostatic abnormalities: diagnosis and treatment].
    Gueddi S; Boehlen F; de Ziegler D; de Moerloose P
    Rev Med Suisse; 2005 Jan; 1(4):279-82. PubMed ID: 15771356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of mefenamic acid and norethisterone on measured menstrual blood loss.
    Cameron IT; Haining R; Lumsden MA; Thomas VR; Smith SK
    Obstet Gynecol; 1990 Jul; 76(1):85-8. PubMed ID: 2359570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative factors for predicting successful hysteroscopic endometrial ablation.
    Gemer O; Kapustian V; Kroll D; Tur-Kaspa I; Segal S
    J Reprod Med; 2003 Sep; 48(9):677-80. PubMed ID: 14562630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.